Table 3.
Statements | Scalea, n (%) | Weighted mean (SD) | |||||
1 | 2 | 3 | 4 | 5 | 6 | ||
I do not understand the concept. | 28 (12.0) | 28 (12.0) | 57 (24.3) | 40 (17.1) | 51 (21.8) | 30 (12.8) | 3.6 (1.6) |
I reject such developments categorically. | 26 (11.1) | 33 (14.1) | 40 (17.1) | 47 (20.0) | 40 (17.1) | 47 (20.0) | 3.8 (1.6) |
I have my doubts about these developments. | 49 (20.9) | 53 (22.6) | 68 (29.0) | 30 (12.8) | 16 (6.8) | 17 (7.3) | 2.8 (1.5) |
I see potential in these developments. | 26 (11.1) | 44 (18.8) | 60 (25.6) | 60 (25.6) | 25 (10.7) | 18 (7.7) | 3.3 (1.4) |
I would recommend such developments to my patients. | 18 (7.7) | 49 (20.9) | 42 (17.9) | 56 (23.9) | 34 (14.5) | 34 (14.5) | 3.6 (1.5) |
I find such developments excellent and would like to put them into practice as soon as possible | 18 (7.7) | 26 (11.1) | 44 (18.8) | 56 (23.9) | 33 (14.1) | 56 (23.9) | 3.5 (1.6) |
aThe participants were asked to indicate their agreement on a scale from 1 to 6, where 1 indicates a strong agreement and 6 a strong disagreement.